The traffic coming to this blog has been increasing as 2010 has rolled along. I'd just like to take this opportunity to thank all the regular readers and welcome all the new ones.
The month of June is significant as the traffic increased by a massive 186% compared to last year, this, in the main, down to the fact that I was writing about the inquest of Canadian teenager, Sara Carlin.
It was important for me to report on Sara's inquest as I believed the Canadian mainstream press were missing key points.
There are two other great Seroxat related blogs that are a wealth of information.
Seroxat Secrets & GSK : Licence To (K) ill
Seroxat Secrets has been running around four years and its author offers some great opinion. He also has a great timeline regarding Seroxat which stems from 1998 onwards. The author continues to pursue his search for the truth. He, like me, had a particularly difficult time withdrawing from Seroxat and he writes with a great passion.
GSK : Licence To (K) ill, authored by The Truthman, continues to press for answers too. The Truthman was also affected by Seroxat and his brilliantly named blog arrived on the scene a short while after mine and Seroxat Secrets. Another author who offers great opinion.
Both blogs have search boxes and both authors should be commended for their staying power and dedication to the cause.
Keep on keeping on guys.
I salute you both.
**In other related news, GlaxoSmithKline's second- quarter profit slumped by a massive 92%, hurt by costs to settle lawsuits over the Avandia diabetes medicine and the Paxil antidepressant.
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
"It's not about what they tell you, it's about what they don't."
~ Bob Fiddaman, Author, Blogger, Researcher, Recipient of two Human Rights awards
Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist
Subscribe to:
Post Comments (Atom)
Please contact me if you would like a guest post considered for publication on my blog.
No comments: